Inthera raises CHF10.5M in series A

On May 31, oncology company Inthera Bioscience AG (Zurich, Switzerland) raised CHF10.5 million ($10.8 million) in a series A round led by Merck Ventures. Also participating were Aglaia BioMedical Ven...